Latest news
How Bridgebio Pharma Inc. (BBIO) Affects Rotational Strategy Timing - Stock Traders DailyStock Traders Daily · Sun, 09 Aug 2026 03:02:01 GMTFARALLON CAPITAL MANAGEMENT LLC Adds to BridgeBio Pharma Inc (BB - GuruFocusGuruFocus · Sat, 08 Aug 2026 08:26:15 GMTBridgeBio Pharma Inc. R (2CL.MU) Q1 FY2026 earnings call transcript - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 22:45:44 GMTBridgeBio Pharma (BBIO) Wins FDA Review For Encaleret In ADH1 - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 01:11:00 GMTBridgeBio Pharma (NASDAQ: BBIO) CAO sells 2,000 shares in 10b5-1 trading plan - Stock TitanStock Titan · Mon, 03 Aug 2026 20:21:25 GMTBridgeBio Pharma (BBIO) After Its $2.21b Stock Filing Is It A Buy Or Priced In - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 19:09:13 GMTBridgeBio Pharma Announces Date for Second Quarter 2026 Financial Results and Business Update - Quiver QuantitativeQuiver Quantitative · Mon, 03 Aug 2026 11:42:00 GMTPiper Sandler Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Maintains Target Price $111 - MoomooMoomoo · Mon, 03 Aug 2026 11:31:00 GMT